SEC Company Response from Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306) (TNXP) — Feb 6, 2020
Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)
Date: Feb. 6, 2020 · CIK: 0001430306 · Accession: 0001387131-20-001061
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-235976
Letter
A.G.P./Alliance Global Partners
Madison Avenue
New York, New York 10022
February 6, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
F St., NE
Washington, D.C. 20549
RE: Tonix Pharmaceuticals Holding Corp. (the “Company”)
File No. 333-235976
Registration Statement on Form S-1
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, A.G.P./Alliance Global Partners, as representative of the underwriters, hereby joins the request of the Company that the effective date of the above-referenced Registration Statement be accelerated so that it will become effective at 5:15 p.m. Eastern Time on February 6, 2020, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very truly yours,
A.G.P./Alliance Global Partners
Show Raw Text
CORRESP
1
filename1.htm
A.G.P./Alliance
Global Partners
590
Madison Avenue
New
York, New York 10022
February
6, 2020
VIA
EDGAR
U.S.
Securities and Exchange Commission
100
F St., NE
Washington,
D.C. 20549
RE:
Tonix Pharmaceuticals
Holding Corp. (the “Company”)
File No. 333-235976
Registration Statement on Form S-1
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933,
as amended, A.G.P./Alliance Global Partners, as representative of the underwriters, hereby joins the request of the Company that
the effective date of the above-referenced Registration Statement be accelerated so that it will become effective at 5:15 p.m.
Eastern Time on February 6, 2020, or as soon thereafter as practicable.
Pursuant
to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably
anticipated to be invited to participate in the distribution of the securities, as many copies of the proposed form of preliminary
prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed
by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange
Act of 1934, as amended, in connection with the above-referenced issue.
Very truly yours,
A.G.P./Alliance Global Partners
By: Tom Higgins
/s/
Tom Higgins
Title: Managing Director